Filter
67
Text search:
antiepileptic
medications
Featured
Recommendations
10
New Publications
11
Language
Document type
No document type
52
Guidelines
7
Manuals
3
Studies & Reports
3
Fact sheets
2
Countries / Regions
South Africa
4
Ethiopia
3
Uganda
3
India
3
South Sudan
2
Kenya
2
Latin America and the Carribbean
2
Sierra Leone
1
Nigeria
1
USA
1
Ghana
1
Zimbabwe
1
Nepal
1
Zambia
1
Syria
1
Malawi
1
Middle East and North Africa
1
South–East Asia Region
1
Paraguay
1
Authors & Publishers
Publication Years
Category
Countries
18
Clinical Guidelines
5
Women & Child Health
3
Capacity Building
2
Toolboxes
Mental Health
36
Disability
4
COVID-19
3
Pharmacy
3
TB
2
Natural Hazards
1
Zika
1
[Updated 2015]
Scoping Question: In adults with acute convulsive seizures in first-level care or in the community (when no IV access is available), which antiepileptic medications produce benefit
...
Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compa
...
SCOPING QUESTION: In adults with established status epilepticus (i.e., seizures persisting after the first-line treatment with benzodiazepines [or benzodiazepines-resistant status epilepticus]), which anti-epileptic medications are associated with c
...
Q12: Should the treatment be similar in individuals with intellectual disability and epilepsy compared to people with epilepsy only?
Q9. In adults and children with convulsive epilepsy in remission, when should treatment be discontinued?
SCOPING QUESTION: For adults and children with medication-resistant convulsive epilepsy, which anti-epileptic medications produce benefits and/or harm in the specified outcomes when compared to a placebo or a comparator?
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i
...
Bulletin of the World Health Organization, 2001, 79 (4)
Bridging the Gap
This is the fifteenth edition of the lecture notes. They were first published in 1987 as a summary of the material used in the biannual epilepsy teaching weekend organised under the auspices of the UK Chapter of the International League against Epilepsy.
(Lecture series consist of a total of 59 cha
...
SCOPING QUESTION: In adults with acute convulsive seizures, where intravenous access is available, which first-line anti- epileptic medication should be used to abort seizures when compared to comparator?
Q3: Are pharmacotherapies safe and effective for the treatment of psychostimulant dependence (maintenance or relapse prevention) in non-specialized settings?
Brief review of selected topics
The following pages provide a focus on selected areas in relation to neurology. The specialists who contributed the reviews are listed in the Project Team and Partners
Neurology Atlas (2004)
What you can do
Anxiety Disorders
Chapter F.4
These guidance notes on stress, grief and loss have been compiled by IMC’s Mental Health Advisor, Dr. Lynne Jones, for organizations working with Hurricane Katrina-affected populations. They represent lessons learned regarding mental health activities from IMC’s international experiences in disa
...
Accessed: 10.03.2019
mhGAP Training Manual for the mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings – version 2.0 (for field testing)
Low- and middle-income countries (LMICs) experience a high disease burden for epilepsy, a chronic neurological condition.The authors evaluate the cost-effectiveness of community health workers (CHWs) to improve adherence to medication for epilepsy in South Africa. They found that utilizing CHWs to i
...
